PEREGRINE CAPITAL MANAGEMENT LLC Ultragenyx Pharmaceutical Inc. Transaction History

PEREGRINE CAPITAL MANAGEMENT LLC portfolio value:

$4.92M
portfolio value

PEREGRINE CAPITAL MANAGEMENT LLC quarter portfolio value change:

-30.59%
quarter

Ultragenyx Pharmaceutical Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.24% -6.57K shares -2.56M $41.41 118.92K
Q2 2022 share Decrease -0.08% -98 shares -1.63M $59.66 125.50K
Q1 2022 share Increase 0.00% 125.60K shares 9.12M $72.62 125.60K